Assessment of the Impact of Rapid Point-of-Care CD4 Testing in Primary Healthcare Clinic Settings: A Survey Study of Client and Provider Perspectives
Autor: | Anna Coutsoudis, Noluthando Ngomane, Elizabeth Spooner, Shabashini Reddy, Gita Ramjee, Tarylee Reddy, Photini Kiepiela, Andrew Gibbs, Nozipho Luthuli |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
030231 tropical medicine Clinical Biochemistry Primary health care Qualitative survey patients Article 03 medical and health sciences 0302 clinical medicine point-of-care CD4+ t testing qualitative survey acceptability medicine 030212 general & internal medicine Point of care lcsh:R5-920 business.industry Public health Survey research Antiretroviral therapy healthcare providers primary healthcare clinics Family medicine Anxiety medicine.symptom lcsh:Medicine (General) business Healthcare providers |
Zdroj: | Diagnostics Volume 10 Issue 2 Diagnostics, Vol 10, Iss 2, p 81 (2020) |
ISSN: | 2075-4418 |
Popis: | Background: The high burden of disease in South Africa presents challenges to public health services. Point-of-care (POC) technologies have the potential to address these gaps and improve healthcare systems. This study ascertained the acceptability and impact of POC CD4 testing on patients&rsquo health and clinical management. Methods: We conducted a qualitative survey study with patients (n = 642) and healthcare providers (n = 13) at the Lancers Road (experienced POC) and Chesterville (non-experienced POC) primary healthcare (PHC) clinics from September 2015 to June 2016. Results: Patients (99%) at Lancers and Chesterville PHCs were positive about POC CD4 testing, identifying benefits: No loss/delay of test results (6.4%), cost/time saving (19.5%), and no anxiety (5.1%), and 58.2% were ready to initiate treatment. Significantly more patients at Chesterville than Lancers Road PHC felt POC would provide rapid clinical decision making (64.7% vs. 48.1% p < 0.0001) and better clinic accessibility (40.4% vs. 24.7% 0.0001) respectively. Healthcare providers thought same-day CD4 results would impact: Clinical management (46.2%), patient readiness (46.2%), and adherence (23.0%), and would reduce follow-up visits (7.7%), while 38.5% were concerned that further tests and training (15.4%) were required before antiretroviral therapy (ART) initiation. Conclusion: The high acceptability of POC CD4 testing and the immediate health, structural, and clinical management benefits necessitates POC implementation studies. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |